Reports that the final shortlist of coronavirus vaccine candidates in Operation Warp Speed has been decided are premature, says US company Novavax Inc.–with a strong suggestion from the biotech’s R&D chief that his company is still very much in the running.
Operation Warp Speed, President Trump’s special project to accelerate the delivery of a coronavirus vaccine by late 2020, was launched on 15 May, with ex-industry vaccines